Dr. Caroline C Berube, MD is a Hematology / Oncology Specialist - Hematologist (Blood) practicing in Stanford, CA
She has not yet shared a personalized biography with Doctor.com.
| University | Degree | Focus | Graduated |
|---|---|---|---|
| Universite Laval, Quebec, Canada | Other Degree | MD | Not Specified |
| Laval University / Faculty of Medicine | Medical Degree | 1983 | |
| Universite Laval, Faculte De Medecine | Other Degree | 1983 |
| Institution | Focus | Year |
|---|---|---|
| Internship - Laval University, Canada | 1984 | |
| Residency - Laval University, Canada | 1987 | |
| Fellowship - Mcmaster University, Hamilton, Canada | 1991 |
| Certification | Cert. Body | Year |
|---|---|---|
Sub-Specialty: Medical Oncology | Internal Medicine | 1990 |
| Internal medicine | Internal Medicine | 1988 |
| Publication | Publisher | Title | Published |
|---|---|---|---|
| Other Publication | Haematologica | Sequential azacitidine plus lenalidomide combination | 2013 |
| Other Publication | AMERICAN JOURNAL OF HEMATOLOGY | Accessory splenules in autoimmune hemolytic anemia | 2013 |
| Other Publication | LEUKEMIA | Safety, efficacy and biological predictors of response to sequential azacitidine and lenalidomide | 2012 |
| Other Publication | HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | Phase I trial of a novel human monoclonal antibody mAb216 in patients with relapsed or refractory B | 2012 |
| Other Publication | AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY | Moxifloxacin-acetaminophen | 2011 |
| Other Publication | AMERICAN JOURNAL OF HEMATOLOGY | Second-line mitoxantrone, etoposide | 2010 |
| Other Publication | PHARMACOGENETICS AND GENOMICS | Extending and evaluating a warfarin dosing algorithm that includes CYP4F2 | 2010 |
| Other Publication | BLOOD | Activity of the tyrosine kinase inhibitor PKC412 | 2005 |
| Other Publication | Haematologica | Sequential azacitidine plus lelidomide combition | 2013 |
| Other Publication | AMERICAN JOURL OF HEMATOLOGY | Accessory splenules in autoimmune hemolytic anemia | 2013 |
| Other Publication | LEUKEMIA | Safety, efficacy and biological predictors of response to sequential azacitidine and lelidomide for | 2012 |
| Other Publication | HAEMATOLOGICA-THE HEMATOLOGY JOURL | Phase I trial of a novel human monoclol antibody mAb216 in patients with relapsed or refractory B | 2012 |
| Other Publication | AMERICAN JOURL OF HEALTH-SYSTEM PHARMACY | Moxifloxacin-acetaminophen | 2011 |
| Other Publication | AMERICAN JOURL OF HEMATOLOGY | Second-line mitoxantrone, etoposide | 2010 |
| Other Publication | BLOOD | Activity of the tyrosine kise inhibitor PKC412 | 2005 |
Dr. Caroline C Berube, MD has not yet indicated the hospitals that she is affiliated with.
Years In Practice: 34 (started in 1990)
Accepts New Patients: Yes
Dr. Caroline C Berube, MD has not yet listed the medications that she commonly prescribes.
Dr. Caroline C Berube, MD has not yet added any information about her practice's billing policies and payment options.
